Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
A., Ciani, F., Pasquini, E., la, Marca G., Scholte, H
FSEN1 was identified as a small-molecule inhibitor of FSP1 through chemical screening 118 , and subsequent structural analyses revealed that FSEN1 occupies the substrate-binding pocket of FSP1 in a position analogous to CoQ observed in the enzyme active site, providing structural insight into inhibitor recognition 119
Reconstitution Note (Research Use Only) Allow the vial to reach ambient temperature before reconstitution
Mechanisms of long COVID and the path toward therapeutics
The benefits of HA-based non-conventional formulations for the management of RA are also explored, such as HA-based surface-decorated nanocarrier systems ensuring specific targeting of drugs to inflamed joints, enhancing therapeutic efficacy and reducing off-target distribution of drugs
* In solvent : -80C, 6 months
